Siemens Healthineers AG (ETR:SHL)
Germany · Delayed Price · Currency is EUR 39.13
-0.39 (-0.99%)
Aug 31, 2026, 5:35 PM CET
Siemens Healthineers AG Income Statement
Financials in millions EUR. Fiscal year is October - September.
Millions EUR. Fiscal year is Oct - Sep.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
| 23,168 | 23,375 | 22,363 | 21,680 | 21,714 | 17,997 | |
Revenue Growth | -0.92% | 4.52% | 3.15% | -0.16% | 20.65% | 24.46% |
Cost of Revenue | 14,128 | 14,345 | 13,895 | 13,971 | 13,577 | 11,045 |
Gross Profit | 9,040 | 9,030 | 8,468 | 7,709 | 8,137 | 6,952 |
Selling, General & Admin | 3,872 | 3,887 | 3,681 | 3,607 | 3,408 | 2,817 |
Research & Development | 1,950 | 1,958 | 1,918 | 1,866 | 1,785 | 1,546 |
Other Operating Expenses | -20 | 21 | 60 | 103 | 20 | 21 |
Operating Expenses | 5,802 | 5,866 | 5,659 | 5,576 | 5,213 | 4,384 |
Operating Income | 3,238 | 3,164 | 2,809 | 2,133 | 2,924 | 2,568 |
Interest Expense | -407 | -425 | -476 | -296 | -118 | -83 |
Interest & Investment Income | 95 | 99 | 119 | 85 | 48 | 33 |
Earnings From Equity Investments | -9 | -10 | -2 | 3 | 2 | 5 |
Currency Exchange Gain (Loss) | 328 | 328 | 564 | 1,198 | -2,022 | -273 |
Other Non Operating Income (Expenses) | -351 | -303 | -491 | -1,195 | 1,967 | 153 |
EBT Excluding Unusual Items | 2,894 | 2,853 | 2,523 | 1,928 | 2,801 | 2,403 |
Pretax Income | 2,894 | 2,853 | 2,523 | 1,928 | 2,801 | 2,403 |
Income Tax Expense | 654 | 686 | 564 | 403 | 746 | 658 |
Earnings From Continuing Operations | 2,240 | 2,167 | 1,959 | 1,525 | 2,055 | 1,745 |
Minority Interest in Earnings | -27 | -23 | -17 | -16 | -17 | -18 |
Net Income | 2,213 | 2,144 | 1,942 | 1,509 | 2,038 | 1,727 |
Net Income to Common | 2,213 | 2,144 | 1,942 | 1,509 | 2,038 | 1,727 |
Net Income Growth | 1.89% | 10.40% | 28.69% | -25.96% | 18.01% | 22.39% |
Shares Outstanding (Basic) | 1,121 | 1,120 | 1,118 | 1,119 | 1,123 | 1,100 |
Shares Outstanding (Diluted) | 1,121 | 1,125 | 1,123 | 1,124 | 1,128 | 1,104 |
Shares Change | -0.49% | 0.11% | -0.01% | -0.37% | 2.19% | 9.91% |
EPS (Basic) | 1.97 | 1.91 | 1.74 | 1.35 | 1.82 | 1.57 |
EPS (Diluted) | 1.97 | 1.91 | 1.73 | 1.34 | 1.81 | 1.57 |
EPS Growth | 2.32% | 10.41% | 29.10% | -25.97% | 15.29% | 12.14% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
Free Cash Flow | 2,607 | 2,714 | 2,130 | 1,281 | 1,652 | 2,259 |
Free Cash Flow Per Share | 2.33 | 2.41 | 1.90 | 1.14 | 1.47 | 2.05 |
Dividend Per Share | 1.000 | 1.000 | 0.950 | 0.950 | 0.950 | 0.850 |
Dividend Growth | 5.26% | 5.26% | 0% | 0% | 11.77% | 6.25% |
Gross Margin | 39.02% | 38.63% | 37.87% | 35.56% | 37.47% | 38.63% |
Operating Margin | 13.98% | 13.54% | 12.56% | 9.84% | 13.47% | 14.27% |
Profit Margin | 9.55% | 9.17% | 8.68% | 6.96% | 9.39% | 9.60% |
Free Cash Flow Margin | 11.25% | 11.61% | 9.53% | 5.91% | 7.61% | 12.55% |
EBITDA | 4,022 | 4,074 | 3,736 | 3,229 | 3,941 | 3,307 |
EBITDA Margin | 17.36% | 17.43% | 16.71% | 14.89% | 18.15% | 18.38% |
D&A For EBITDA | 784 | 910 | 927 | 1,096 | 1,017 | 739 |
EBIT | 3,238 | 3,164 | 2,809 | 2,133 | 2,924 | 2,568 |
EBIT Margin | 13.98% | 13.54% | 12.56% | 9.84% | 13.47% | 14.27% |
Effective Tax Rate | 22.60% | 24.04% | 22.35% | 20.90% | 26.63% | 27.38% |